Gugler R, Leschik M, Dengler H J
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):229-34. doi: 10.1007/BF00614022.
The pharmacokinetics of quercetin, a flavonoid, have been studied in 6 volunteers after single intravenous (100 mg) and oral (4 g) doses. The data after iv administration were analyzed according to a two compartment open model with half lives of 8.8 +/- 1.2 min for the alpha phase and 2.4 +/- 0.2 h for the beta phase (predominant half life), respectively. Protein binding was greater than 98%. The apparent volume of distribution was small at 0.34 +/- 0.03 1/kg. Of the intravenous dose 7.4 +/- 1.2% was excreted in urine as a conjugated metabolite, and 0.65 +/- 0.1% was excreted unchanged. After oral administration no measurable plasma concentrations could be detected, nor was any quercetin found in urine, either unchanged or in a metabolized form. These results exclude absorption of more than 1% of unchanged drug. Recovery in faeces after the oral dose was 53 +/- 5%, which suggests extensive degradation by microorganisms in the gut. The data obtained show that oral administration of flavonoids may be of questionable value.
已对6名志愿者单次静脉注射(100毫克)和口服(4克)剂量的黄酮类化合物槲皮素的药代动力学进行了研究。静脉给药后的数据分析采用二室开放模型,α相半衰期为8.8±1.2分钟,β相(主要半衰期)为2.4±0.2小时。蛋白结合率大于98%。表观分布容积较小,为0.34±0.03升/千克。静脉注射剂量中,7.4±1.2%以结合代谢物形式经尿液排泄,0.65±0.1%以原形排泄。口服给药后,未检测到可测量的血浆浓度,尿液中也未发现任何槲皮素,无论是原形还是代谢形式。这些结果排除了超过1%的原形药物被吸收的可能性。口服剂量后粪便中的回收率为53±5%,这表明肠道中的微生物对其有广泛降解作用。所获得的数据表明,口服黄酮类化合物的价值可能存疑。